Chris Lau

Chris Lau

InvestorPlace Contributor

Expertise: Technology, Biotech

Expertise:

Technology
Biotech

Education:

Bachelor of Science
Project Management Professional

Awards and Accomplishments:

Top 100 Tipranks 2015-2021

About Chris:

Chris has over two decades of investing experience. He is an Honors B.Sc graduate (with distinction) in Science and Economics. He holds a Project Management Professional designation

Chris focuses on the technology, cyclical, and healthcare sector. He runs a newsletter with speculative Triple-baggers.

His investment strategy is based on finding undervalued stocks trading at a steep discount to their intrinsic value.

Follow Chris on DIY Value Investing.

Recent Articles

Qualcomm, Inc. (QCOM) Stock Drifts Lower as Uncertainties Build

By Chris Lau, InvestorPlace Contributor

Qualcomm's NXPI buyout is lagging as European Regulators ask questions, but the real worry for QCOM stock is Apple's refusal to pay.

Micron Technology (MU) Stock Is a Screaming Buy Below $30

By Chris Lau, InvestorPlace Contributor

Micron is screaming deep-value as the stock drops. If prospects are strong, why are markets ignoring the positive fundamentals for MU stock?

Will Teva Pharmaceutical Industries Ltd (ADR) (TEVA) Stock Catch a Break?

By Chris Lau, InvestorPlace Contributor

TEVA stock is in the spotlight again when it reports quarterly results this week. Teva Pharmaceutical investors will look closely at cash flow and debt.

Can Tesla Inc (TSLA) Stock Reclaim All-Time Highs in August?

By Chris Lau, InvestorPlace Contributor

While Tesla is trying to mount a comeback, it's safe to say July belonged to the bears. Will TSLA stock return to its lofty perch next month?

Amazon.com, Inc. (AMZN) Stock Looks Vulnerable and Plump

By Chris Lau, InvestorPlace Contributor

Is Amazon's post-earnings selloff and partial recovery a sign that AMZN stock is bulletproof ... or that it's about to get more volatile?

Load More